How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?
  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?
  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?
  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

5 Minimum evidence standards

The evidence considered by NICE primarily focuses on diagnostic accuracy, failure rates, training and implementation of the AI technologies in varied non-NHS settings. All the technologies that have been recommended for use in the NHS during the evidence generation period have some implementation experience in the NHS. The companies did not report any safety concerns. The technologies demonstrated potential to be cost effective for opportunistic detection of vertebral fragility fractures. But, more information is still needed to fully understand the benefits they may provide. More evidence is needed on:

  • the AI technologies' impacts on health-related quality of life

  • diagnostic accuracy and failure rates of the AI technologies compared with NHS standard care

  • longer-term clinical and resource-use impacts of AI technologies to the NHS

  • the impact on the care pathway.

This evidence is essential to future NICE decision making. It will also potentially inform the optimum use and implementation of AI technologies for vertebral fragility fracture detection in the NHS.